Clinical Convergence®: The Learning Pathway in Atopic Dermatitis: Maximizing Positive Outcomes for Your Patients
Dermatology
Curriculum:
The Learning Pathway in Atopic Dermatitis: Maximizing Positive Outcomes for Your Patients
The Learning Pathway in Atopic Dermatitis: Maximizing Positive Outcomes for Your Patients
Credits:
ANCC Contact Hours 0.75 AMA PRA Category 1 Credit(s) ™
ANCC Contact Hours 0.75 AMA PRA Category 1 Credit(s) ™
Launch Date:
August 30, 2018
August 30, 2018
Expiration Date:
The accreditation for this activity has expired.
The accreditation for this activity has expired.
Primary Audience:
US-based dermatology and allergy/immunology clinicians who manage patients with atopic dermatitis (AD)
Relevant Terms:
Atopic Dermatitis (AD)
Jonathan I. Silverberg, MD, PhD, MPH
Jonathan I. Silverberg, MD, PhD, MPH (Chair)
Associate Professor, Dermatology, Preventive Medicine, and Medical Social Sciences
Northwestern University Feinberg School of Medicine
Director, Northwestern Medicine Multidisciplinary Eczema Center
Director, Patch Testing Clinic
Northwestern Memorial Hospital
Chicago, IL
Bio
Jonathan I. Silverberg, MD, PhD, MPH, is an associate professor in the Departments of Dermatology, Preventive Medicine, and Medical Social Sciences at Northwestern University Feinberg School of Medicine in Chicago, Illinois. Dr Silverberg is the director of the Northwestern Medicine Multidisciplinary Eczema Center and founded the Multidisciplinary Eczema Clinic at Northwestern Medicine. He is also the director of the contact dermatitis clinic and photobiologic testing at Northwestern Memorial Hospital, which provides comprehensive evaluation and management of skin allergies and photosensitivity. He was the recipient of the Georg Rajka Medal from the International Society of Atopic Dermatitis, the Teacher of the Year Award in the Department of Dermatology at Northwestern Memorial Hospital, and the Everett C. Fox Research Award from the American Academy of Dermatology.
Dr Silverberg completed both his medical degree and master of public health degree in 2009 at State University of New York, Downstate Medical Center in Brooklyn, New York. His master's thesis focused on the protective role of herpesviridae on atopic dermatitis and other allergic disorders as part of the broader "hygiene hypothesis." He completed his doctorate in 2006 with thesis studies in neuroimmunology focused on murine immune responses after a seizure. He performed his residency training at St. Luke's-Roosevelt Hospital Center at Columbia University in New York City, New York.
His research goals are to better understand the risk factors and medical comorbidities of atopic dermatitis in the U.S. population. Dr Silverberg has authored 141 scientific articles and book chapters, including studies of the epidemiology of atopic dermatitis and "big data" research. He has extensive experience with database development, instrument development and deployment, and statistical programming.
Dr Silverberg is an associate editor for the British Journal of Dermatology and Current Dermatology Reports and is on the editorial board of Cutis. He is a member of the National Eczema Association Scientific Advisory Committee and American Academy of Dermatology Atopic Dermatitis Expert Resource Group, and he is chair of the Society of Investigative Dermatology Atopic Dermatitis Epidemiology Working Group. He is also a member of the Alpha Omega Alpha honor society, American Academy of Dermatology, Society of Investigative Dermatology, American Contact Dermatitis Society, Illinois Dermatologic Society, and Chicago Dermatologic Society.
Dr Silverberg completed both his medical degree and master of public health degree in 2009 at State University of New York, Downstate Medical Center in Brooklyn, New York. His master's thesis focused on the protective role of herpesviridae on atopic dermatitis and other allergic disorders as part of the broader "hygiene hypothesis." He completed his doctorate in 2006 with thesis studies in neuroimmunology focused on murine immune responses after a seizure. He performed his residency training at St. Luke's-Roosevelt Hospital Center at Columbia University in New York City, New York.
His research goals are to better understand the risk factors and medical comorbidities of atopic dermatitis in the U.S. population. Dr Silverberg has authored 141 scientific articles and book chapters, including studies of the epidemiology of atopic dermatitis and "big data" research. He has extensive experience with database development, instrument development and deployment, and statistical programming.
Dr Silverberg is an associate editor for the British Journal of Dermatology and Current Dermatology Reports and is on the editorial board of Cutis. He is a member of the National Eczema Association Scientific Advisory Committee and American Academy of Dermatology Atopic Dermatitis Expert Resource Group, and he is chair of the Society of Investigative Dermatology Atopic Dermatitis Epidemiology Working Group. He is also a member of the Alpha Omega Alpha honor society, American Academy of Dermatology, Society of Investigative Dermatology, American Contact Dermatitis Society, Illinois Dermatologic Society, and Chicago Dermatologic Society.
Eric Simpson, MD, MCR
Eric Simpson, MD, MCR
Professor of Dermatology, Department of Dermatology
Oregon Health & Science University
Portland, OR
Bio
Eric L. Simpson, MD, MCR, is a professor of dermatology in the Department of Dermatology at Oregon Health & Science University in Portland, OR. Dr Simpson received his medical degree from the University of Texas Southwestern Medical School in Dallas, TX. His internship was completed at Baylor University Medical School in Dallas and his residency at Oregon Health & Science University. Dr Simpson completed postgraduate studies at Oregon Health & Science University with a certificate in Human Investigations and a master’s degree in Clinical Research.
Dr Simpson practices medical dermatology with special interests in chronic inflammatory skin diseases and skin cancer. He is actively involved in clinical research and is currently funded by the National Institutes of Health and industry partners to study new approaches to chronic skin disease treatment and prevention.
Dr Simpson's collaborations are global in scope and he has been invited to present his research and approach to patient care at international conferences in Europe, North and South America, and Asia. He has published over 80 scientific articles in several high-impact peer-reviewed journals, including the New England Journal of Medicine and The Lancet.
Dr Simpson supports patient advocacy by serving as the co-chair of the Scientific Advisory Committee for the National Eczema Association. He also serves on the executive committee of the Harmonizing Outcome Measures in Eczema (HOME), a volunteer group of patients, providers, and other stakeholders whose mission is to improve the quality of eczema research to better suit the needs of patients and policy-makers.
| 1. | Develop treatment plans for patients with AD that reflect evidence-based guidelines, use of new and emerging therapeutic options, and strategies to optimize short-term control and long-term management of the disease | 2. | Assess for and manage quality-of-life issues and psychosocial comorbidities in patients with AD |
| 1. | Develop treatment plans for patients with AD that reflect evidence-based guidelines, use of new and emerging therapeutic options, and strategies to optimize short-term control and long-term management of the disease |
| 2. | Assess for and manage quality-of-life issues and psychosocial comorbidities in patients with AD |
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and RMEI Medical Education, LLC. The Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CONTINUING MEDICAL EDUCATION
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
DISCLOSURE OF CONFLICTS OF INTEREST
The Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
- Jonathan I. Silverberg, MD, PhD, MPH, has affiliations with AbbVie, Anaptysbio, Asana, Eli Lilly, Galderma, Glenmark, Kiniksa, LEO Pharma Inc., Menlo Therapeutics Inc., Pfizer, Realm, Regeneron-Sanofi, and Roivant (Consulting Fees); Regeneron-Sanofi (Speakers’ Bureaus); and Galderma, GlaxoSmithKline, and Regeneron-Sanofi (Contracted Research).
- Eric Simpson, MD, MCR, has affiliations with AbbVie, Eli Lilly, LEO Pharma Inc., Menlo Therapeutics Inc., Pfizer, Regeneron, and Sanofi Genzyme (Consulting Fees); Eli Lilly, Glaxo Smith Kline, LEO Pharma Inc., Novartis, Regeneron Pharmaceuticals, Inc., and Roivant (Contracted Research).
Planners and Managers
The PIM planners and managers have nothing to disclose. RMEI Medical Education, LLC planners and managers have nothing to disclose, except for Misha Mutizwa, MD, who has affiliations with Celgene (Consulting Fees, Speakers’ Bureau).
The PIM planners and managers have nothing to disclose. RMEI Medical Education, LLC planners and managers have nothing to disclose, except for Misha Mutizwa, MD, who has affiliations with Celgene (Consulting Fees, Speakers’ Bureau).
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Estimated time to complete: 45 minutes
Medium: Internet
Medium: Internet
FEE INFORMATION
There is no fee for this educational activity.
There is no fee for this educational activity.
STATEMENT OF COMMERCIAL SUPPORT
This activity is jointly provided by Postgraduate Institute for Medicine and RMEI Medical Education, LLC. This activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.
This activity is jointly provided by Postgraduate Institute for Medicine and RMEI Medical Education, LLC. This activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.
HOW TO RECEIVE CREDIT
By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive up to 0.75 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page. Users must:
By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive up to 0.75 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page. Users must:
- Read the learning objectives and faculty disclosures.
- Participate in the activity.
- Complete the activity evaluation.
Physicians who successfully complete the post-test and evaluation will receive CME credit. You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation. If you would like to contact Postgraduate Institute for Medicine, please email information@pimed.com.
| YOUR FEEDBACK IS IMPORTANT! Complete the Evaluation form for this activity and be entered into a drawing for a $100* Amazon Gift card. *The expense for this gift card is solely funded by RMEI Medical Education, LLC. No supporter funding was used for the expense of this gift card. Rules and Regulations This sweepstakes is managed by RMEI Medical Education, LLC (RMEI), a full-service medical education company. The winner will be selected via automated random drawing on a monthly basis from among all eligible entries and notified through the contact information provided. In accordance with our privacy policy, we do not share your information with any third parties. By entering the sweepstakes, you grant RMEI permission to use your email address to reach you for notification and prize fulfillment. Only individuals who complete the evaluation forms and provide contact information will be eligible to win. Open to those who have a US postal address and who are 18 years or older. Only one prize per person and per household will be awarded. The prize will be a $100 Amazon gift card. If you would like to contact RMEI, please email contact@RMEI.com. |
COURSE VIEWING REQUIREMENTS
| Supported Browsers: Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6.0+ for Mac OSX 10.7 and above | Supported Phones & Tablets: Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above. |
© 2007-2024 HealthCourse, Inc. All rights reserved.
